Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Int J Mol Sci ; 21(19)2020 Sep 30.
Artigo em Inglês | MEDLINE | ID: mdl-33007902

RESUMO

Atherosclerosis-related acute aortic syndromes, such as aortic aneurysms or aortic dissection are life-threatening diseases. Since they develop suddenly and progress rapidly, the establishment of preventive strategies is urgently needed. Quercetin, a flavonoid abundant in various vegetables and fruits, is suggested to reduce the risk of cardiovascular disease. Therefore, in this study, the preventive effect of quercetin was evaluated using a mouse model of aortic aneurysm and dissection. The model was established by administering angiotensin II (Ang II) and ß-aminopropionitrile (BAPN), a lysyl oxidase inhibitor, to mice to induce hypertension and degeneration of the elastic lamina, which would eventually result in the onset of an aortic aneurysm. Ang II, BAPN, and a nitric oxide synthase inhibitor was administered to induce aortic dissection via endothelial dysfunction. Quercetin (60 mg/kg/day) was administered 2 weeks before inducing aortic diseases by the end of the experiments (8 weeks in the aneurysm model, 6 weeks in the dissection model). It was found to reduce the incidence of aneurysm (from 72 to 45%), dissection (from 17 to 10%), and rupture (from 33 to 15%) in mice. Elastin degradation was ameliorated in the quercetin-treated mice compared to that in the mice without quercetin treatment (degradation score 2.9 ± 0.3 vs 2.2 ± 0.2). Furthermore, quercetin suppressed the expression of vascular cell adhesion molecule-1, macrophage infiltration, and pro-matrix metalloproteinase-9 activity. Our results suggest that quercetin might prevent the onset of atherosclerosis-related acute aortic syndromes through its anti-inflammatory and endothelial cell-protective effects.


Assuntos
Aneurisma Aórtico/tratamento farmacológico , Dissecção Aórtica/tratamento farmacológico , Aterosclerose/tratamento farmacológico , Hipertensão/tratamento farmacológico , Quercetina/farmacologia , Aminopropionitrilo/efeitos adversos , Dissecção Aórtica/induzido quimicamente , Dissecção Aórtica/complicações , Dissecção Aórtica/patologia , Angiotensina II/efeitos adversos , Animais , Aorta Torácica/efeitos dos fármacos , Aneurisma Aórtico/induzido quimicamente , Aneurisma Aórtico/complicações , Aneurisma Aórtico/patologia , Aterosclerose/genética , Aterosclerose/patologia , Pressão Sanguínea/efeitos dos fármacos , Modelos Animais de Doenças , Humanos , Hipertensão/induzido quimicamente , Hipertensão/complicações , Hipertensão/patologia , Camundongos , Proteína-Lisina 6-Oxidase/antagonistas & inibidores
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa